top of page

Glenmark reduced Favipiravir price to Rs 75 per tab from Rs 103 per tab earlier

Quick Update:

Glenmark sells the drug, used in the treatment of COVID-19, under the brand name FabiFlu. The oral antiviral favipiravir has been approved under emergency use authorization for the treatment of mild to moderate COVID-19 patients.

Glenmark Pharmaceuticals has said that it has reduced the price of its favipiravir drug to Rs 75 per tablet from Rs 103 per tablet it was charging earlier.


Recent Posts

See All


Rated 0 out of 5 stars.
No ratings yet

Add a rating
bottom of page